Elevated Soluble CD14 and Lower D-Dimer Are Associated With Cigarette Smoking and Heavy Episodic Alcohol Use in Persons Living With HIV

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2015 Jul 17

PMID 26181818

Citations 17

Authors

Patricia A Cioe

Jason Baker

Erna M Kojic

Nur Onen

John Hammer

Pragna Patel

Christopher W Kahler

Affiliations

Soon will be listed here.

Abstract

Background: Persons living with HIV are at increased risk for cardiovascular disease in part because of persistent inflammation and coagulation activation.

Methods: We examined whether smoking and heavy episodic alcohol use (defined as 5 or more drinks on one occasion) were associated with greater monocyte activation (soluble CD14) and coagulation (D-dimer) in participants in the Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (the "SUN" Study), a prospective observational cohort.

Results: Using regression analysis (n = 689), current smoking compared with nonsmoking was associated with significantly elevated soluble CD14 (B = 135.57, 95% confidence interval: 84.95 to 186.19, P < 0.001), whereas heavy alcohol use compared with nonheavy use was associated with significantly lower D-dimer levels (B = -0.059, 95% confidence interval: -0.102 to -0.016, P = 0.007).

Conclusions: Smoking cessation should be encouraged by HIV care providers to improve mortality outcomes from all causes of death, particularly cardiovascular disease.

Citing Articles

Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls.

Knudsen A, Bouazzi R, Afzal S, Gelpi M, Benfield T, Hogh J BMC Infect Dis. 2022; 22(1):451.

PMID: 35546661 PMC: 9097376. DOI: 10.1186/s12879-022-07450-y.

Preservation of Gastrointestinal Mucosal Barrier Function and Microbiome in Patients With Controlled HIV Infection.

Mak G, Zaunders J, Bailey M, Seddiki N, Rogers G, Leong L Front Immunol. 2021; 12:688886.

PMID: 34135912 PMC: 8203413. DOI: 10.3389/fimmu.2021.688886.

Chronic obstructive pulmonary disease in HIV.

Byanova K, Kunisaki K, Vasquez J, Huang L Expert Rev Respir Med. 2020; 15(1):71-87.

PMID: 33167728 PMC: 7856058. DOI: 10.1080/17476348.2021.1848556.

Inflammation in Relation to Intensity and Duration of Cigarette Smoking Among People Living with HIV.

Poudel K, Poudel-Tandukar K, Bertone-Johnson E, Pekow P, Vidrine D AIDS Behav. 2020; 25(3):856-865.

PMID: 32986190 DOI: 10.1007/s10461-020-03048-0.

Factor Xa Inhibition Reduces Coagulation Activity but Not Inflammation Among People With HIV: A Randomized Clinical Trial.

Baker J, Wolfson J, Peterson T, Mooberry M, Gissel M, Mystakelis H Open Forum Infect Dis. 2020; 7(2):ofaa026.

PMID: 32055640 PMC: 7008475. DOI: 10.1093/ofid/ofaa026.

References

Rimm E, Williams P, Fosher K, Criqui M, Stampfer M . Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999; 319(7224):1523-8. PMC: 28294. DOI: 10.1136/bmj.319.7224.1523. View

Pieters M, Vorster H, Jerling J, Venter C, Kotze R, Bornman E . The effect of ethanol and its metabolism on fibrinolysis. Thromb Haemost. 2010; 104(4):724-33. DOI: 10.1160/TH10-01-0048. View

Yarnell J, Sweetnam P, Rumley A, Lowe G . Lifestyle factors and coagulation activation markers: the Caerphilly Study. Blood Coagul Fibrinolysis. 2001; 12(8):721-8. DOI: 10.1097/00001721-200112000-00015. View

Galvan F, Bing E, Fleishman J, London A, Caetano R, Burnam M . The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol. 2002; 63(2):179-86. DOI: 10.15288/jsa.2002.63.179. View

van Golde P, Hart H, Kraaijenhagen R, Bouma B, van de Wiel A . Regular alcohol intake and fibrinolysis. Neth J Med. 2002; 60(7):285-8. View

Klatsky A, Armstrong M, Friedman G . Risk of cardiovascular mortality in alcohol drinkers, ex-drinkers and nondrinkers. Am J Cardiol. 1990; 66(17):1237-42. DOI: 10.1016/0002-9149(90)91107-h. View

Lazarus N, Kaplan G, Cohen R, Leu D . Change in alcohol consumption and risk of death from all causes and from ischaemic heart disease. BMJ. 1991; 303(6802):553-6. PMC: 1670864. DOI: 10.1136/bmj.303.6802.553. View

Negri E, La Vecchia C, DAvanzo B, Nobili A, La Malfa R . Acute myocardial infarction: association with time since stopping smoking in Italy. GISSI-EFRIM Investigators. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto. Epidemiologia dei Fattori di Rischio dell'Infarto Miocardico. J Epidemiol Community Health. 1994; 48(2):129-33. PMC: 1059920. DOI: 10.1136/jech.48.2.129. View

Nockher W, Bergmann L, Scherberich J . Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin Exp Immunol. 1994; 98(3):369-74. PMC: 1534504. DOI: 10.1111/j.1365-2249.1994.tb05499.x. View

10.

Lien E, Aukrust P, Sundan A, Muller F, Froland S, Espevik T . Elevated levels of serum-soluble CD14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood. 1998; 92(6):2084-92. View

11.

Burkhalter J, Springer C, Chhabra R, Ostroff J, Rapkin B . Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005; 7(4):511-22. DOI: 10.1080/14622200500186064. View

12.

Wannamethee S, Lowe G, Shaper A, Rumley A, Lennon L, Whincup P . Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J. 2005; 26(17):1765-73. DOI: 10.1093/eurheartj/ehi183. View

13.

Glass T, Ungsedhapand C, Wolbers M, Weber R, Vernazza P, Rickenbach M . Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study. HIV Med. 2006; 7(6):404-10. DOI: 10.1111/j.1468-1293.2006.00400.x. View

14.

Sackoff J, Hanna D, Pfeiffer M, Torian L . Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City. Ann Intern Med. 2006; 145(6):397-406. DOI: 10.7326/0003-4819-145-6-200609190-00003. View

15.

Chander G, Lau B, Moore R . Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. J Acquir Immune Defic Syndr. 2006; 43(4):411-7. PMC: 2704473. DOI: 10.1097/01.qai.0000243121.44659.a4. View

16.

Triant V, Lee H, Hadigan C, Grinspoon S . Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab. 2007; 92(7):2506-12. PMC: 2763385. DOI: 10.1210/jc.2006-2190. View

17.

Kaplan R, Kingsley L, Sharrett A, Li X, Lazar J, Tien P . Ten-year predicted coronary heart disease risk in HIV-infected men and women. Clin Infect Dis. 2007; 45(8):1074-81. DOI: 10.1086/521935. View

18.

DeLorenze G, Weisner C, Tsai A, Satre D, Quesenberry Jr C . Excess mortality among HIV-infected patients diagnosed with substance use dependence or abuse receiving care in a fully integrated medical care program. Alcohol Clin Exp Res. 2010; 35(2):203-10. PMC: 3242701. DOI: 10.1111/j.1530-0277.2010.01335.x. View

19.

Ronksley P, Brien S, Turner B, Mukamal K, Ghali W . Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011; 342:d671. PMC: 3043109. DOI: 10.1136/bmj.d671. View

20.

Sandler N, Wand H, Roque A, Law M, Nason M, Nixon D . Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011; 203(6):780-90. PMC: 3071127. DOI: 10.1093/infdis/jiq118. View